A
Aquestive Therapeutics Inc
NASDAQ:AQST
Aquestive Therapeutics Inc
NASDAQ:AQST
Price:
3.1 USD
1.31%
Market Closed
Updated:
May 29, 2024
Aquestive Therapeutics Inc
Common Shares Outstanding
|
Aquestive Therapeutics Inc
Common Shares Outstanding Peer Comparison
Comparables:
JNJ
BMY
PFE
MRK
LLY
Competitive Common Shares Outstanding Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Common Shares Outstanding | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
A
|
Aquestive Therapeutics Inc
NASDAQ:AQST
|
Common Shares Outstanding
$90.5m
|
CAGR 3-Years
36%
|
CAGR 5-Years
29%
|
CAGR 10-Years
N/A
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Common Shares Outstanding
$2.4B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-2%
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Common Shares Outstanding
$2B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
4%
|
CAGR 10-Years
2%
|
|
|
Pfizer Inc
NYSE:PFE
|
Common Shares Outstanding
$5.7B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-1%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Common Shares Outstanding
$2.5B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-1%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Common Shares Outstanding
$950.4m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-2%
|
See Also
What is Aquestive Therapeutics Inc's Common Shares Outstanding?
Common Shares Outstanding
90.5m
USD
90.5m
USD
Based on the financial report for Mar 31, 2024, Aquestive Therapeutics Inc's Common Shares Outstanding amounts to 90.5m USD.
What is Aquestive Therapeutics Inc's Common Shares Outstanding growth rate?
Common Shares Outstanding CAGR 5Y
29%
29%
Over the last year, the Common Shares Outstanding growth was 62%. The average annual Common Shares Outstanding growth rates for Aquestive Therapeutics Inc have been 36% over the past three years , 29% over the past five years .
You don't have any saved screeners yet
